Rate Video

EBMT 2020 | Outcomes after allo-HSCT for Diamond-Blackfan anemia

Carlo Dufour • 26 Aug 2020

Carlo Dufour, MD, IRCCS Giannina Gaslini, Genoa, Italy, discusses the long-term outcomes after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for Diamond-Blackfan anemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

BMF diagnosis with NGS and gene panels

Carlo Dufour • 1 Sep 2020

Upcoming SAA research: cyclosporine and eltrombopag

Carlo Dufour • 26 Oct 2019

Telomere length screening

Carlo Dufour • 14 Jun 2019

Autoimmune cytopenias following allo-HSCT

Carlo Dufour • 25 Aug 2020

Related Videos

The 2021 MDS armamentarium

Felicitas Thol • 22 Jan 2021

CLIMB THAL-111 and CLIMB SCD-121: CTX001 in β-thalassemia and SCD

Haydar Frangoul • 10 Dec 2020

Multidisciplinary home approach for sickle cell disease

Wally Smith • 30 Nov 2020

Crizanlizumab decreases opioid use for management of vaso-occlusive crises in SCD

Wally Smith • 30 Nov 2020